Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The complement and immunoglobulin levels in NMO patients.
Therapeutic effect of EDTA in experimental model of multiple sclerosis.
Investigation of flow dynamics of liquid phase in a pilot-scale trickle bed reactor using radiotracer technique.
Differential diagnosis, discerning depression from cognition.
Complementary and alternative medicine in alopecia areata.
Selective depletion of CD11c(+) CD11b(+) dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE.
Is cell migration or proliferation dominant in the formation of linear arrays of oligodendrocytes?
Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study.
USPTO list of patent term extensions
TRAIL gene expression analysis in multiple sclerosis patients.
Mitochondrial STAT3 is negatively regulated by SOCS3 and upregulated after spinal cord injury.
Allelic variations in rat MHC class II binding of myelin basic protein peptides correlate with encephalitogenicity.
Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Environmental factors in autoimmune diseases and their role in multiple sclerosis.
High dose Vitamin D intake and quality of life in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.
McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity.
Fully automated grey and white matter spinal cord segmentation.
The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution.
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption.
Modulation of hexadecyl-LPA-mediated activation of mast cells and microglia by a chemical probe of LPA5.
Anisotropic cerebral vascular architecture causes orientation dependency in cerebral blood flow and volume measured with dynamic susceptibility contrast magnetic resonance imaging.
Paraparetic Guillain-Barré syndrome: Non-demyelinating reversible conduction failure restricted to the lower limbs.
Osmotic demyelination syndrome after slow sodium administration in a hyponatremic patient with concurrent hypokalemia.
Activation of Sterol Regulatory Element Binding Factors by Fenofibrate and Gemfibrozil Stimulates Myelination in Zebrafish.
Pages
« first
‹ previous
…
738
739
740
741
742
743
744
745
746
…
next ›
last »